Products listed in Japan’s Foods with Function Claims (FFCs) system should not need health benefit claims to be based on evidence from placebo-controlled trials or systematic literature reviews, a new report claims.
This round-up features South Korea’s re-evaluation of co-enzyme Q10 and other ingredients use in health functional foods, China’s push for scientific reassessment of certain health foods, and Australia’s refusal to change amygdalin rules.
The quality of clinical trials behind products under Japan’s Foods with Function Claims (FFCs) is undermined by a lack of proper protocols, such as the absence of trial registration and transparent study designs, says a new study.
Remote clinical trials are likely to continue even after COVID-19 has waned, mainly due to the high level of convenience that it provides, says a researcher from Australia’s national research institute.
This round-up of new scientific findings looks at how probiotics could be used to reduce insomnia symptoms, how omega-3 and nanocurcumin could alleviate migraine, and new product development potential based on the concept of chrono-nutrition.
Clinical trial findings are becoming ever more important in today’s world as consumers are looking beyond label claims and are actively reading up on the health benefits and evidence of ingredients used in immunity products, according to an expert panel.
The future of microbiome and immunity research should delve deeper into the mechanisms of probiotics through clinical trials, focus on the broader role of metabolites, and consider the use of multi-omics, said an expert panel.
Researchers from Asia, the Middle East, and the West are now trialling omega-3, honey, and even potato resistant starch, on top of vitamins and zinc, as they race to find products that could contribute to the fight against COVID-19 and its symptoms.
The body's absorption of omega-3 increased by six times after taking a supplement that used the self micro-emulsifying delivery system (SMED) from Pharmako Biotechnologies, a series of human clinical trials conducted in Australia has found.